Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Japan Tobacco Inc Receives Manufacturing and Marketing Approval for Stribild Combination Tablets


Monday, 25 Mar 2013 02:00am EDT 

Japan Tobacco Inc announced that it has received manufacturing and marketing approval of a novel anti-HIV drug, Stribild Combination Tablets, in Japan. The Company had filed a New Drug Application (NDA) for this drug with the Japanese Ministry of Health, Labour and Welfare in December 2012. 

Company Quote

3635.0
-9.5 -0.26%
2:00am EDT